Bridging Cultural Differences to Improve HBV Treatment in Asian and Other Diverse Communities

[Guest guest]

http://www.projectsinknowledge.com/cp/index.cfm?jn=1948 & thspage=welcome

Bridging Cultural Differences to Improve HBV Treatment

in Asian and Other Diverse Communities

Advanced Certificate Program V:

This independent CME/CE activity is supported by an educational grant from

Bristol-Myers Squibb

Supported by an independent educational grant from Gilead Sciences Medical

Affairs

Keep up to date with us via twitter!

--------------------------------------------------------------------------------

Projects In Knowledge

Overlook at Great Notch

150 Clove Road

Little Falls, NJ 07424

Tel: (973) 890-8988

Fax: (973) 890-8866

This yearlong online program offers 17 new and engaging, multiple-format CME/CE

courses that are released continuously throughout the year. The

state-of-the-science curriculum, developed by prominent hepatology experts, will

offer clarity and guidance to clinicians on key issues and practice challenges,

such as:

•Methodology for screening and diagnosing HBV

•Prevention strategies (eg, early vaccination, screening during pregnancy)

•Optimal management strategies (including who and when to treat, and issues with

long-term therapy)

•Cultural differences in patient communications

Co-Chairs:

M. Di Bisceglie, MD, FACP

Chairman, Internal Medicine

Chief of Hepatology

Saint Louis University

School of Medicine

St. Louis, Missouri

G. Gish, MD

Medical Director

Liver Transplant Program

Chief, Division of Hepatology and Complex GI

California Pacific Medical Center

San Francisco, California

Learning Objectives:

•Assess screening, diagnosis, prevention strategies (eg, vaccination), and

optimal treatment interventions of patients with or at risk of chronic HBV

infection through an understanding of the epidemiology, risk factors, and

disease burden imposed by HBV infection.

•Analyze cultural differences in patient communication and management of HBV

infection (comparing the Asian and Pacific-Islander, Latino, black, and white

communities) to bridge these differences and improve patient outcomes.

•Assess status of molecular tests in determining when to treat, optimal

treatment selection and on-treatment response in chronic HBV-infected patients

with diverse ethnic backgrounds to improve patient outcomes.

•Formulate anti-HBV treatment strategies, considering efficacy, therapeutic

endpoints, safety, and resistance profiles of currently and emerging antiviral

agents to improve response rates in culturally diverse patients with chronic HBV

infection.

•Implement optimal treatment selection for special populations with chronic HBV

infection to improve outcomes.

•Integrate personalized anti-HBV prescribing, treatment, and monitoring

strategies to prevent, reduce, or manage drug resistance in patients with

chronic HBV infection.

•Analyze barriers to initiating timely anti-HBV treatment interventions and

strategies to overcome these barriers in the practice setting.

•Implement monitoring and follow-up to optimize anti-HBV therapy response for

improved patient outcomes (prevent/manage drug resistance, identify/manage

therapy-related side effects ensure adherence).

_________________________________________________________________

The New Busy think 9 to 5 is a cute idea. Combine multiple calendars with

Hotmail.

http://www.windowslive.com/campaign/thenewbusy?tile=multicalendar & ocid=PID28326:\

:T:WLMTAGL:ON:WL:en-US:WM_HMP:042010_5